DRI Healthcare Trust (DHT.UN) Competitors C$13.93 -0.13 (-0.92%) As of 07/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesBuy This Stock DHT.UN vs. ATT, AGRA, MJ, BIO, BBM, BAMM, LOVE, CSI, CALI, and DCNNShould you be buying DRI Healthcare Trust stock or one of its competitors? The main competitors of DRI Healthcare Trust include Abattis Bioceuticals (ATT), Agraflora Organics International (AGRA), Amplify Alternative Harvest ETF (MJ), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), BooksAMillion (BAMM), Cannara Biotech (LOVE), Chemesis International (CSI), China Auto Logistics (CALI), and Digicann Ventures (DCNN). These companies are all part of the "drug manufacturers - specialty & generic" industry. DRI Healthcare Trust vs. Its Competitors Abattis Bioceuticals Agraflora Organics International Amplify Alternative Harvest ETF Bio-Rad Laboratories Blueberries Medical BooksAMillion Cannara Biotech Chemesis International China Auto Logistics Digicann Ventures Abattis Bioceuticals (CNSX:ATT) and DRI Healthcare Trust (TSE:DHT.UN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, risk, media sentiment, institutional ownership, earnings, profitability and analyst recommendations. Do institutionals & insiders believe in ATT or DHT.UN? 48.4% of DRI Healthcare Trust shares are held by institutional investors. 0.1% of DRI Healthcare Trust shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media refer more to ATT or DHT.UN? In the previous week, Abattis Bioceuticals' average media sentiment score of 0.00 equaled DRI Healthcare Trust'saverage media sentiment score. Company Overall Sentiment Abattis Bioceuticals Neutral DRI Healthcare Trust Neutral Which has stronger earnings and valuation, ATT or DHT.UN? DRI Healthcare Trust has higher revenue and earnings than Abattis Bioceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbattis BioceuticalsN/AN/AN/AN/AN/ADRI Healthcare TrustC$193.66MN/AC$9.73M-C$0.05-278.60 Do analysts prefer ATT or DHT.UN? DRI Healthcare Trust has a consensus target price of C$18.58, suggesting a potential upside of 33.41%. Given DRI Healthcare Trust's stronger consensus rating and higher probable upside, analysts plainly believe DRI Healthcare Trust is more favorable than Abattis Bioceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abattis Bioceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00DRI Healthcare Trust 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is ATT or DHT.UN more profitable? DRI Healthcare Trust has a net margin of 5.02% compared to Abattis Bioceuticals' net margin of 0.00%. DRI Healthcare Trust's return on equity of 2.06% beat Abattis Bioceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Abattis BioceuticalsN/A N/A N/A DRI Healthcare Trust 5.02%2.06%4.22% SummaryDRI Healthcare Trust beats Abattis Bioceuticals on 9 of the 9 factors compared between the two stocks. Get DRI Healthcare Trust News Delivered to You Automatically Sign up to receive the latest news and ratings for DHT.UN and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DHT.UN vs. The Competition Export to ExcelMetricDRI Healthcare TrustDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapN/AC$2.17BC$5.56BC$6.27BDividend Yield3.26%2.92%3.80%6.72%P/E Ratio-278.604.1828.0553.96Price / SalesN/A583.92446.641,133.24Price / CashN/A10.3535.8483.29Price / Book1.4911.288.274.99Net IncomeC$9.73MC$21.15BC$3.24BC$301.20M7 Day PerformanceN/A0.56%1.47%0.61%1 Month Performance5.29%5.33%8.06%4.23%1 Year Performance16.76%3.25%30.37%25.99% DRI Healthcare Trust Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DHT.UNDRI Healthcare TrustN/AC$13.93-0.9%C$18.58+33.4%+19.0%C$0.00C$193.66M-278.60N/AATTAbattis BioceuticalsN/AN/AN/AN/AC$0.00N/A0.00N/AGap UpAGRAAgraflora Organics InternationalN/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading VolumeMJAmplify Alternative Harvest ETFN/AN/AN/AN/A$0.00N/A0.007Gap UpBIOBio-Rad LaboratoriesN/AN/AN/AN/A$0.00N/A0.008,000High Trading VolumeBBMBlueberries MedicalN/AN/AN/AN/A$0.00N/A0.008High Trading VolumeBAMMBooksAMillionN/AN/AN/AN/A$0.00N/A0.00142High Trading VolumeLOVECannara BiotechN/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading VolumeCSIChemesis InternationalN/AN/AN/AN/A$0.00N/A0.00147,000Gap DownHigh Trading VolumeCALIChina Auto LogisticsN/AN/AN/AN/A$0.00N/A0.0040Gap DownHigh Trading VolumeDCNNDigicann VenturesN/AN/AN/AN/A$0.00N/A0.00N/A Related Companies and Tools Related Companies Abattis Bioceuticals Competitors Agraflora Organics International Competitors Amplify Alternative Harvest ETF Competitors Bio-Rad Laboratories Competitors Blueberries Medical Competitors BooksAMillion Competitors Cannara Biotech Competitors Chemesis International Competitors China Auto Logistics Competitors Digicann Ventures Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:DHT.UN) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredMiss This Window And You Miss EverythingThere’s a moment in every crypto cycle when everything just clicks — and that moment is now. This is the ph...Crypto Swap Profits | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DRI Healthcare Trust Please log in to your account or sign up in order to add this asset to your watchlist. Share DRI Healthcare Trust With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.